BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38677269)

  • 1. Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation.
    Li Z; Mo RL; Gong JF; Han L; Wang WF; Huang DK; Xu JG; Sun YJ; Chen S; Han GC; Sun DQ
    Phytomedicine; 2024 Jul; 129():155661. PubMed ID: 38677269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation.
    Sun C; Han B; Zhai Y; Zhao H; Li X; Qian J; Hao X; Liu Q; Shen J; Kai G
    Free Radic Biol Med; 2022 Feb; 180():220-235. PubMed ID: 35074488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity Against Oral Cancer Cells Through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts.
    Liu YC; Peng BR; Hsu KC; El-Shazly M; Shih SP; Lin TE; Kuo FW; Chou YC; Lin HY; Lu MC
    Mar Drugs; 2020 Jul; 18(8):. PubMed ID: 32718084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1.
    Tian L; Lu Y; Yang T; Deng Z; Xu L; Yao W; Ma C; Li X; Zhang J; Liu Y; Wang J
    Redox Biol; 2019 Apr; 22():101149. PubMed ID: 30822690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol extract of Eclipta prostrata induces multiple myeloma ferroptosis via Keap1/Nrf2/HO-1 axis.
    Li W; Yin X; Fu H; Liu J; Weng Z; Mao Q; Zhu L; Fang L; Zhang Z; Ding B; Tong H
    Phytomedicine; 2024 Jun; 128():155401. PubMed ID: 38507850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.
    Tian H; Zhang D; Gao Z; Li H; Zhang B; Zhang Q; Li L; Cheng Q; Pei D; Zheng J
    Cancer Gene Ther; 2014 Oct; 21(10):416-26. PubMed ID: 25236495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling.
    Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
    J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Peng LY; An L; Sun NY; Ma Y; Zhang XW; Liu WH; Liu BL; Li P; Chen J
    Am J Chin Med; 2019; 47(5):1113-1131. PubMed ID: 31352786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formononetin, a bioactive isoflavonoid constituent from Astragalus membranaceus (Fisch.) Bunge, ameliorates type 1 diabetes mellitus via activation of Keap1/Nrf2 signaling pathway: An integrated study supported by network pharmacology and experimental validation.
    Chen H; Lou Y; Lin S; Tan X; Zheng Y; Yu H; Jiang R; Wei Y; Huang H; Qi X; Zhang R; Liu Z; Wu J
    J Ethnopharmacol; 2024 Mar; 322():117576. PubMed ID: 38104880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1.
    Arora R; Sawney S; Saini V; Steffi C; Tiwari M; Saluja D
    Mol Cancer; 2016 Oct; 15(1):64. PubMed ID: 27756327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer.
    Huang S; Wang H; Chen W; Zhan M; Xu S; Huang X; Lin R; Shen H; Wang J
    J Cell Mol Med; 2020 Jan; 24(2):1599-1613. PubMed ID: 31782270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
    Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
    Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotanshinone I Inhibits Pancreatic Cancer Progression
    Huang W; Dai Y; Xu L; Mao Y; Huang Z; Ji X
    Curr Cancer Drug Targets; 2023; 23(9):731-741. PubMed ID: 37018533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy.
    Zhang D; Hou Z; Aldrich KE; Lockwood L; Odom AL; Liby KT
    Mol Cancer Ther; 2021 Sep; 20(9):1692-1701. PubMed ID: 34158350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icaritin activates Nrf2/Keap1 signaling to protect neuronal cells from oxidative stress.
    Xu Y; Lu X; Zhang L; Wang L; Zhang G; Yao J; Sun C
    Chem Biol Drug Des; 2021 Jan; 97(1):111-120. PubMed ID: 32654377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-Targeted Immunotoxin Exerts Antitumor Effects on Esophageal Cancers by Increasing ROS Accumulation and Inducing Apoptosis via Inhibition of the Nrf2-Keap1 Pathway.
    Yang Y; Tian Z; Ding Y; Li X; Zhang Z; Yang L; Zhao F; Ren F; Guo R
    J Immunol Res; 2018; 2018():1090287. PubMed ID: 30596104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dihydrotanshinone I as an ERp57 inhibitor with anti-breast cancer properties via the UPR pathway.
    Shi W; Han H; Zou J; Zhang Y; Li H; Zhou H; Cui G
    Biochem Pharmacol; 2021 Aug; 190():114637. PubMed ID: 34062127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.